✦ LIBER ✦

Survival-Adjusted Multiple-Event Analysis for the Evaluation of Treatment Effects of Zoledronic Acid in Patients with Bone Metastases from Solid Tumors

✍ Scribed by Major, Pierre P.; Cook, Richard J.; Chen, Bee-Lian; Zheng, Ming

Book ID: 121272580
Publisher: CIG Media Group, LP.
Year: 2005
Tongue: English
Weight: 121 KB
Volume: 2
Category: Article
ISSN: 1543-2912
DOI: 10.3816/SCT.2005.n.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Zoledronic acid for the treatment of bon

Zoledronic acid for the treatment of bone metastases in patients with breast cancer and other solid tumors

✍ Leo Lacerna; John Hohneker 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Normalization of bone markers is associa

Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid

✍ Allan Lipton; Richard Cook; Fred Saad; Pierre Major; Patrick Garnero; Evangelos 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB 👁 2 views

## Abstract ## BACKGROUND. For patients with bone metastases, high N‐telopeptide of type I collagen (NTX) levels correlate with increased risks of skeletal‐related events and death. However, the relation between NTX decreases and clinical benefits is unclear. ## METHODS. Correlations between NTX

Cost-effectiveness of denosumab vs zoled

Cost-effectiveness of denosumab vs zoledronic acid for prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States

✍ Stopeck, Alison; Rader, Michael; Henry, David; Danese, Mark; Halperin, Marc; Con 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 264 KB

Prospective observational study of treat

Prospective observational study of treatment pattern, effectiveness and safety of zoledronic acid therapy beyond 24 months in patients with multiple myeloma or bone metastases from solid tumors

✍ Wyngaert, T.; Delforge, M.; Doyen, C.; Duck, L.; Wouters, K.; Delabaye, I.; Wout 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 347 KB

304 ORAL Early normalization of elevated

304 ORAL Early normalization of elevated baseline bone resorption marker levels by zoledronic acid and improved survival in patients with bone metastases from solid tumors

✍ A. Lipton; R.J. Cook; P. Major; M.R. Smith; R.E. Coleman 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 63 KB

PCN116 Cost-Effectiveness of Denosumab V

PCN116 Cost-Effectiveness of Denosumab Versus Zoledronic Acid (ZA) for the Prevention of Skeletal-related Events (SRE) in Patients with Bone Metastases from Solid Tumors in the Netherlands

✍ Lothgren, M.; Bracco, A.; Lucius, B.; Northridge, K.; Halperin, M.; Macarios, D. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB